NL8402017A - Nieuwe peptiden. - Google Patents

Nieuwe peptiden. Download PDF

Info

Publication number
NL8402017A
NL8402017A NL8402017A NL8402017A NL8402017A NL 8402017 A NL8402017 A NL 8402017A NL 8402017 A NL8402017 A NL 8402017A NL 8402017 A NL8402017 A NL 8402017A NL 8402017 A NL8402017 A NL 8402017A
Authority
NL
Netherlands
Prior art keywords
hct
gel
acid
salt
sct
Prior art date
Application number
NL8402017A
Other languages
English (en)
Dutch (nl)
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of NL8402017A publication Critical patent/NL8402017A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NL8402017A 1983-06-27 1984-06-26 Nieuwe peptiden. NL8402017A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH349683 1983-06-27
CH3496/83A CH657858A5 (de) 1983-06-27 1983-06-27 Substanz aus der gruppe der calcitonine.

Publications (1)

Publication Number Publication Date
NL8402017A true NL8402017A (nl) 1985-01-16

Family

ID=4257248

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8402017A NL8402017A (nl) 1983-06-27 1984-06-26 Nieuwe peptiden.

Country Status (16)

Country Link
US (1) US4845080A (xx)
JP (1) JPS6019721A (xx)
AU (1) AU578897B2 (xx)
BE (1) BE900012A (xx)
CH (1) CH657858A5 (xx)
DE (1) DE3423370A1 (xx)
DK (1) DK311884A (xx)
FR (1) FR2549070B1 (xx)
GB (1) GB2142335B (xx)
IL (1) IL72219A (xx)
IT (1) IT1199150B (xx)
LU (1) LU85422A1 (xx)
NL (1) NL8402017A (xx)
NZ (1) NZ208669A (xx)
SE (1) SE8403377L (xx)
ZA (1) ZA844857B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
US5010174A (en) * 1987-07-08 1991-04-23 Mitsubishi Petrochemical Co., Ltd. Novel calcitonin derivative and salt thereof
JP3179538B2 (ja) * 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
US5571788A (en) * 1991-12-09 1996-11-05 Ciba-Geigy Corporation Stable calcitonin pharmaceutical compositions
CA2161108A1 (en) * 1993-04-23 1994-11-10 Herbert J. Evans Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5965698A (en) * 1993-04-23 1999-10-12 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US5928896A (en) * 1993-04-23 1999-07-27 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US5952465A (en) * 1993-04-23 1999-09-14 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
US6084066A (en) * 1993-10-29 2000-07-04 Virginia Commonwealth University Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
EP1251867A4 (en) 2000-02-04 2004-12-08 Unigene Lab Inc NASAL CALCITON INFORMATION
WO2014195364A1 (en) * 2013-06-04 2014-12-11 Basf Se Process for reducing the total organic carbon in wastewater

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU555838B2 (en) * 1981-07-15 1986-10-09 Celltech Limited Human calcitonin precursor polyprotein structural gene
WO1985000043A1 (en) * 1983-06-15 1985-01-03 Kingdon Craig R Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents

Also Published As

Publication number Publication date
SE8403377L (sv) 1984-12-28
BE900012A (fr) 1984-12-27
GB2142335A (en) 1985-01-16
IL72219A (en) 1988-07-31
AU2990784A (en) 1985-01-03
SE8403377D0 (sv) 1984-06-25
FR2549070A1 (fr) 1985-01-18
IL72219A0 (en) 1984-10-31
CH657858A5 (de) 1986-09-30
NZ208669A (en) 1988-06-30
AU578897B2 (en) 1988-11-10
IT8448461A0 (it) 1984-06-27
DK311884D0 (da) 1984-06-26
DK311884A (da) 1984-12-28
US4845080A (en) 1989-07-04
JPS6019721A (ja) 1985-01-31
ZA844857B (en) 1985-02-27
FR2549070B1 (fr) 1988-02-05
GB2142335B (en) 1986-09-17
GB8415884D0 (en) 1984-07-25
DE3423370A1 (de) 1985-01-17
LU85422A1 (de) 1985-03-26
IT1199150B (it) 1988-12-30

Similar Documents

Publication Publication Date Title
BAUMANN et al. The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone
O’DONNELL et al. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves’ disease
Banks et al. Permeability of the murine blood-brain barrier to some octapeptide analogs of somatostatin.
Bakker et al. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity, and in vivo application in animals
NL8402017A (nl) Nieuwe peptiden.
GORDEN et al. Evidence for “big” and “little” components of human plasma and pituitary growth hormone
Nett et al. A radioimmunoassay for gonadotropin-releasing hormone (Gn-RH) in serum
Hennessy et al. STIMULATION OF THYROCALCITONIN SECRETION BY PENTAGASTRIN AND CALCIUM IN TWO PATIENTS WITH MEDULLARY CARCINOMA OF THE THYROID.
Goldfine et al. Intracellular binding sites for insulin are immunologically distinct from those on the plasma membrane
Banks et al. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine
WATANABE et al. Detailed kinetic analysis of adrenocorticotropin secretion by dispersed rat anterior pituitary cells in a microperifusion system: effects of ovine corticotropin-releasing factor and arginine vasopressin
Giorgio et al. Hormone receptors: III. Properties of glucagon-binding proteins isolated from liver plasma membranes
Frohman et al. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man.
EP1094074A2 (en) Radioactively-labeled somatostatin derived peptides for imaging and therapeutic uses
Ranga et al. Growth hormone-releasing factor stimulation test in depression
Daughaday et al. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH
Stening et al. Effect of cholecystokinin and caerulein on gastrin-and histamine-evoked gastric secretion
Davis et al. Sustained inhibitory actions of a potent antagonist of gonadotropin-releasing hormone in postmenopausal women
Skamene et al. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones
TW202214674A (zh) 一種放射性核種標記化合物及其應用
Ekman et al. Radioimmunoassay of delta sleep-inducing peptide using an iodinated p-hydroxyphenylpropionic acid derivative as tracer
GAVIN III et al. Radioreceptor assay of insulin: Comparison of plasma and pancreatic insulins and proinsulins
BURHOL et al. Somatostatin release and plasma molecular somatostatin components in man
Norman et al. Radioimmunoassay studies with human growth hormone and a pituitary lipid mobilizing factor
Daughaday et al. Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E domain: description of a free E domain peptide in serum

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed